Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|July 5, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patientsKonstantina Panoutsopoulou, Margaritis Avgeris, Paraskevi Magkou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
BMC Cancer|April 5, 2013
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortiumDietmar Pils, Dan Tong, Gudrun Hager, et al.
International Journal of Cancer|April 27, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortiumEva Obermayr, Thomas Mohr, Eva Schuster, et al.
International Journal of Cancer|May 6, 2024
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortiumGesa Fromhage, Eva Obermayr, Natalia Bednarz-Knoll, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2015
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD studyMani Nassir, Jun Guan, Hrvoje Luketina, et al.
BMC Cancer|September 19, 2013
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortiumAnna Bachmayr-Heyda, Stefanie Aust, Georg Heinze, et al.
Cancers|September 9, 2020
Definition and Independent Validation of a Proteomic-Classifier in Ovarian CancerSabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2013
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortiumDietmar Pils, Anna Bachmayr-Heyda, Katharina Auer, et al.
BMC Genomics|August 17, 2016
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancerMartin Svoboda, Anastasia Meshcheryakova, Georg Heinze, et al.
Pageof 19